Tech Company Financing Transactions
Numerate Funding Round
Numerate, operating out of San Francisco, secured $5.5 million from Foundation Capital and Lanza techVentures.
Transaction Overview
Company Name
Announced On
3/18/2009
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series B
Investors
Foundation Capital (Lead Investor) (Adam Grosser)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1501 Mariposa St. 426
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Numerate engineers rather than discovers drugs. We have built and validated our Drug Engineering Process to deliver leads faster, cheaper and more predictably.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guido Lanza
Chief Scientific Officer
John Griffin
Chief Technical Officer
Brandon Allgood
Vice President
Uwe Klein
Browse more venture capital transactions:
Prev: 3/18/2009: House Party venture capital transaction
Next: 3/19/2009: Buzznet venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs